Spyre Therapeutics (SYRE) Net Margin (2015 - 2023)

Spyre Therapeutics posted quarterly Net Margin of 31552.47% for Q2 2023, down 2798079.0% year-on-year from N/an in Q2 2022, and down 239.13% on a QoQ basis from 9304.04% in Q1 2023.

Spyre Therapeutics (SYRE) has 7 years of Net Margin data on file, last reported at 31552.47% in Q2 2023.

  • For the quarter ending Q2 2023, Net Margin fell 2798079.0% year-over-year to 31552.47%; the trailing twelve-month figure through Mar 2024 stood at 52939.68% (down 4626148.0% YoY), and the FY2023 full-year result was 38238.15%, down 3463939.0% from the prior year.
  • Net Margin for Q2 2023 stood at 31552.47%, down from 9304.04% in the prior quarter.
  • Across five years, Net Margin topped out at 56.92% in Q2 2021 and bottomed at 31552.47% in Q2 2023.
  • The 3-year median for Net Margin is 3571.68% (2022), against an average of 7632.49%.
  • The widest annual swing landed in 2022, when Net Margin plunged 351476 bps; it then slumped 2798079 bps in 2023.
  • A 3-year view of Net Margin shows it stood at 561.09% in 2021, then slumped by 1897 bps to 11203.57% in 2022, then tumbled by 182 bps to 31552.47% in 2023.
  • The last three Net Margin figures came in at 31552.47% (Q2 2023), 9304.04% (Q1 2023), and 11203.57% (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 34.53%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 17.65%
10 Spyre Therapeutics 5.55 Bn 5.55 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 -31,552.47%
Mar 31, 2023 -9,304.04%
Dec 31, 2022 -11,203.57%
Sep 30, 2022 -10,479.31%
Jun 30, 2022 -3,571.68%
Mar 31, 2022 -1,794.13%
Dec 31, 2021 -561.09%
Sep 30, 2021 -169.23%
Jun 30, 2021 -56.92%
Jun 30, 2018 -395.58%
Mar 31, 2018 -536.56%
Dec 31, 2017 -436.75%
Sep 30, 2017 -623.47%
Jun 30, 2017 -447.60%
Mar 31, 2017 -635.03%
Dec 31, 2016 -439.70%
Sep 30, 2016 -542.91%
Jun 30, 2016 -395.48%
Mar 31, 2016 -529.34%
Dec 31, 2015 -251.55%
Sep 30, 2015 -318.08%
Jun 30, 2015 -41.64%